Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage

Marco Papa, Achille Gaspardone, Gabriele Fracasso, Silvia Ajello, Gaetano Gioffrè, Maria Iamele, Cesare Iani, Alberto Margonato

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Transcatheter patent foramen ovale (PFO) closure might be effective in improving migraines. To assess the efficacy of PFO closure in migraineurs with a moderate to large right-to-left shunt and instrumental evidence of embolic cerebral damage, 76 highly symptomatic migraineurs were prospectively investigated. The presenting clinical syndrome was stroke in 16 patients, repeated transient ischemic attack in 32 patients, and lone migraine associated with cerebral ischemic lesions on magnetic resonance imaging in 28 patients. Migraine severity was assessed before PFO closure and monthly for 6 months after discontinuation of antiplatelet therapy. At the end of 12 months of follow-up, the averaged postprocedural total score was compared with the baseline score. Transcatheter PFO closure was successful in all patients, and the 12-month PFO closure rate was 97%. The baseline total migraine score was similar in patients with stroke, transient ischemic attack, and lone migraine (6.8 ± 1.6, 6.7 ± 1.4, and 6.9 ± 1.7 respectively, p = NS). After a mean follow-up of 13.7 ± 2.4 months, no recurrent cerebrovascular episodes had occurred. At the end of the follow-up period, a significant reduction in the total migraine score was observed in all groups, regardless of the initial clinical presentation. Migraine was completely abolished in 35 patients (46%), improved in 27 (36%), and unchanged in 14 (18%). The proportion of patients with migraine suppression and improvement was similar in the 3 groups. In conclusion, in highly symptomatic migraineurs with previous ischemic cerebral events and instrumental evidence of cerebral embolism, transcatheter PFO closure can result in improvement of migraine severity in a high percentage of patients.

Original languageEnglish
Pages (from-to)434-439
Number of pages6
JournalThe American Journal of Cardiology
Volume104
Issue number3
DOIs
Publication statusPublished - Aug 1 2009

Fingerprint

Patent Foramen Ovale
Migraine Disorders
Transient Ischemic Attack
Stroke
Intracranial Embolism
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage. / Papa, Marco; Gaspardone, Achille; Fracasso, Gabriele; Ajello, Silvia; Gioffrè, Gaetano; Iamele, Maria; Iani, Cesare; Margonato, Alberto.

In: The American Journal of Cardiology, Vol. 104, No. 3, 01.08.2009, p. 434-439.

Research output: Contribution to journalArticle

Papa, Marco ; Gaspardone, Achille ; Fracasso, Gabriele ; Ajello, Silvia ; Gioffrè, Gaetano ; Iamele, Maria ; Iani, Cesare ; Margonato, Alberto. / Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage. In: The American Journal of Cardiology. 2009 ; Vol. 104, No. 3. pp. 434-439.
@article{3992953b623a4124ae4572b165a292f9,
title = "Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage",
abstract = "Transcatheter patent foramen ovale (PFO) closure might be effective in improving migraines. To assess the efficacy of PFO closure in migraineurs with a moderate to large right-to-left shunt and instrumental evidence of embolic cerebral damage, 76 highly symptomatic migraineurs were prospectively investigated. The presenting clinical syndrome was stroke in 16 patients, repeated transient ischemic attack in 32 patients, and lone migraine associated with cerebral ischemic lesions on magnetic resonance imaging in 28 patients. Migraine severity was assessed before PFO closure and monthly for 6 months after discontinuation of antiplatelet therapy. At the end of 12 months of follow-up, the averaged postprocedural total score was compared with the baseline score. Transcatheter PFO closure was successful in all patients, and the 12-month PFO closure rate was 97{\%}. The baseline total migraine score was similar in patients with stroke, transient ischemic attack, and lone migraine (6.8 ± 1.6, 6.7 ± 1.4, and 6.9 ± 1.7 respectively, p = NS). After a mean follow-up of 13.7 ± 2.4 months, no recurrent cerebrovascular episodes had occurred. At the end of the follow-up period, a significant reduction in the total migraine score was observed in all groups, regardless of the initial clinical presentation. Migraine was completely abolished in 35 patients (46{\%}), improved in 27 (36{\%}), and unchanged in 14 (18{\%}). The proportion of patients with migraine suppression and improvement was similar in the 3 groups. In conclusion, in highly symptomatic migraineurs with previous ischemic cerebral events and instrumental evidence of cerebral embolism, transcatheter PFO closure can result in improvement of migraine severity in a high percentage of patients.",
author = "Marco Papa and Achille Gaspardone and Gabriele Fracasso and Silvia Ajello and Gaetano Gioffr{\`e} and Maria Iamele and Cesare Iani and Alberto Margonato",
year = "2009",
month = "8",
day = "1",
doi = "10.1016/j.amjcard.2009.03.061",
language = "English",
volume = "104",
pages = "434--439",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage

AU - Papa, Marco

AU - Gaspardone, Achille

AU - Fracasso, Gabriele

AU - Ajello, Silvia

AU - Gioffrè, Gaetano

AU - Iamele, Maria

AU - Iani, Cesare

AU - Margonato, Alberto

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Transcatheter patent foramen ovale (PFO) closure might be effective in improving migraines. To assess the efficacy of PFO closure in migraineurs with a moderate to large right-to-left shunt and instrumental evidence of embolic cerebral damage, 76 highly symptomatic migraineurs were prospectively investigated. The presenting clinical syndrome was stroke in 16 patients, repeated transient ischemic attack in 32 patients, and lone migraine associated with cerebral ischemic lesions on magnetic resonance imaging in 28 patients. Migraine severity was assessed before PFO closure and monthly for 6 months after discontinuation of antiplatelet therapy. At the end of 12 months of follow-up, the averaged postprocedural total score was compared with the baseline score. Transcatheter PFO closure was successful in all patients, and the 12-month PFO closure rate was 97%. The baseline total migraine score was similar in patients with stroke, transient ischemic attack, and lone migraine (6.8 ± 1.6, 6.7 ± 1.4, and 6.9 ± 1.7 respectively, p = NS). After a mean follow-up of 13.7 ± 2.4 months, no recurrent cerebrovascular episodes had occurred. At the end of the follow-up period, a significant reduction in the total migraine score was observed in all groups, regardless of the initial clinical presentation. Migraine was completely abolished in 35 patients (46%), improved in 27 (36%), and unchanged in 14 (18%). The proportion of patients with migraine suppression and improvement was similar in the 3 groups. In conclusion, in highly symptomatic migraineurs with previous ischemic cerebral events and instrumental evidence of cerebral embolism, transcatheter PFO closure can result in improvement of migraine severity in a high percentage of patients.

AB - Transcatheter patent foramen ovale (PFO) closure might be effective in improving migraines. To assess the efficacy of PFO closure in migraineurs with a moderate to large right-to-left shunt and instrumental evidence of embolic cerebral damage, 76 highly symptomatic migraineurs were prospectively investigated. The presenting clinical syndrome was stroke in 16 patients, repeated transient ischemic attack in 32 patients, and lone migraine associated with cerebral ischemic lesions on magnetic resonance imaging in 28 patients. Migraine severity was assessed before PFO closure and monthly for 6 months after discontinuation of antiplatelet therapy. At the end of 12 months of follow-up, the averaged postprocedural total score was compared with the baseline score. Transcatheter PFO closure was successful in all patients, and the 12-month PFO closure rate was 97%. The baseline total migraine score was similar in patients with stroke, transient ischemic attack, and lone migraine (6.8 ± 1.6, 6.7 ± 1.4, and 6.9 ± 1.7 respectively, p = NS). After a mean follow-up of 13.7 ± 2.4 months, no recurrent cerebrovascular episodes had occurred. At the end of the follow-up period, a significant reduction in the total migraine score was observed in all groups, regardless of the initial clinical presentation. Migraine was completely abolished in 35 patients (46%), improved in 27 (36%), and unchanged in 14 (18%). The proportion of patients with migraine suppression and improvement was similar in the 3 groups. In conclusion, in highly symptomatic migraineurs with previous ischemic cerebral events and instrumental evidence of cerebral embolism, transcatheter PFO closure can result in improvement of migraine severity in a high percentage of patients.

UR - http://www.scopus.com/inward/record.url?scp=67651085605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651085605&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2009.03.061

DO - 10.1016/j.amjcard.2009.03.061

M3 - Article

C2 - 19616680

AN - SCOPUS:67651085605

VL - 104

SP - 434

EP - 439

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 3

ER -